Home › 2026-10752
Patient-Focused Drug Development for Nonhealing Chronic Wounds; Public Meeting; Request for Comments
Read on FederalRegister.gov · Official PDF · Docket on Regulations.gov · Submit a comment · Add to calendar (.ics)
Summary (from the Federal Register abstract)
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Patient-Focused Drug Development for Nonhealing Chronic Wounds." The purpose of the public meeting is to obtain patient perspectives about the impact of nonhealing chronic wounds on daily life, patient views on treatment approaches, factors to consider when selecting a treatment, and what they consider when determining whether to participate in a clinical trial.
- Document type
- Notice
- Federal Register document number
- 2026-10752
- Published
- May 29, 2026
- Action
- Notice of public meeting; request for comments.
- Docket
- FDA-2026-N-5057
- Comments posted on Regulations.gov (at last check)
- 16
- DATES section (from the document)
- The hybrid public meeting will be held on August 25, 2026, from 10:00 a.m. to 4:30 p.m., Eastern Time and will take place in person and virtually. Either electronic or written comments on this public meeting must be submitted by October 26, 2026. See the SUPPLEMENTARY INFORMATION section for registration date and information.
- Topics (auto-tagged)
- Clinical
Source: Federal Register API, document 2026-10752. Federal Register text is a U.S. government work. Confirm dates in the official document; later documents may extend, reopen or correct them.